この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Pari J.に依頼
Australia
Medical Advisor/Clinical Research professional with PhD and 10+ years of global experience in Healthcare Industry
プロフィール概要
専門分野
サービス
Writing
Technical Writing
Research
Market Research,
Feasibility Study,
Fact Checking,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Product Development
Formulation
職務経験
Medical affairs and Clinical Science Professional/Medical Science Liaison
Medtronic
1月 2018 - 8月 2020
Clinical Study Start-up Specialist
IQVIA
9月 2017 - 12月 2017
Clinical Start-up and Regulatory Specialist (Medical writer/Medical Communication)
Syneos Health (Previously INCResearch)
9月 2015 - 8月 2017
Clinical Research Professional (Study Manager for Pharmaceutical trials)
PRA Health Sciences
5月 2013 - 9月 2015
Medical Science Liaison
Illawarra Health and Medical Research Institute
5月 2011 - 5月 2013
Research Scientist
Wollongong University
1月 2007 - 6月 2012
Senior Clinical Science Associate
Health Management and Economic Research Center - Isfahan University
9月 2004 - 9月 2006
学歴
PhD - Pharmacology
Wollongong University
1月 2009 - 6月 2012
Master of Science in Medicinal and Pharmaceutical Chemistry - Research
Wollongong University
1月 2007 - 11月 2008
University of Isfahan
Bachelor of Chemistry
10月 2000 - 6月 2004
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
(2013). In vivo pharmacological evaluations of novel olanzapine analogues in rats: a potential new avenue for the treatment of schizophrenia . PloS one.
(2012). Novel olanzapine analogues presenting a reduced H1 receptor affinity and retained 5HT2A/D2 binding affinity ratio . BMC pharmacology.
(2012). Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects . Journal of Neurochemistry.
(2006). Mathematical model for determination of colloid osmotic pressure: The role of albumin-globulin ratio. Journal of Research in Medical Science. Journal of Research in Medical Science.
CONFERENCE PAPER
(2012). Development of novel antipsychotic drugs with lower obesogenic effects. The 32nd Annual Meeting of The Australian Neuroscience Society.
CONFERENCE ABSTRACT
(2011). Development of novel antipsychotic drugs based on olanzapine that display reduced weight gain and metabolic side effects. 24th European Congress of Neuropsychopharmacology.
(2011). In vivo pharmacological evaluation of novel olanzapine analogues in rat: Potential novel antipsychotic drugs with lower obesogenic effect. 3rd European Conference on Schizophrenia Research.